Therapeutic plasma exchange decreases plasma anti‐SARS‐CoV‐2 spike IgG without increasing the proximate incidence of COVID‐19

Postvaccination antibody titres predict protection against COVID-19 in patients with autoimmune diseases: survival analysis in a prospective cohort

(2022) Sakir Ahmed et al.   ANNALS OF THE RHEUMATIC DISEASES

Low‐density lipoprotein apheresis is associated with removal of SARS‐CoV ‐2 antibodies

(2022) Sebastian Bertram et al.   THERAPEUTIC APHERESIS AND DIALYSIS

SARS-CoV-2 IgG spike protein antibody response in mRNA-1273 Moderna® vaccinated patients on maintenance immunoapheresis – a cohort study

(2022) Martina Gaggl et al.   Frontiers in Immunology

Adaptive immunity to SARS-CoV-2 and COVID-19

(2021) Alessandro Sette et al.   CELL

Evaluating the elimination status of medications used for COVID-19 during hemoperfusion and therapeutic plasma exchange: A review

(2021) Shervin Shokouhi et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Comparison of SARS-CoV-2 Antibody Response Following Vaccination With BNT162b2 and mRNA-1273

(2021) Deborah Steensels et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans

(2021) Jackson S. Turner et al.   NATURE

Mechanisms of SARS-CoV-2 entry into cells

(2021) Cody B. Jackson et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Potently neutralizing and protective human antibodies against SARS-CoV-2

(2020) Seth J. Zost et al.   NATURE

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue

(2019) Anand Padmanabhan et al.   JOURNAL OF CLINICAL APHERESIS

Effect of therapeutic plasma exchange on immunoglobulins in myasthenia gravis

(2016) Jeffrey T. Guptill et al.   AUTOIMMUNITY